Business Intelligence Network - The Vision for BI and Beyond

HighPoint Solutions is Selected to Develop an Incentive Compensation Plan for a New Benign Prostatic Hyperplasia

Published: June 26, 2008

The goal of the plan is to motivate the field sales force and ensure the alignment of tactical activities with the product's strategic goals and budgets.

HighPoint Solutions LLC, a premier provider of business-driven IT solutions, recently announced it has been selected to develop an Incentive Compensation Plan for a new Benign Prostatic Hyperplasia (BPH) product currently under FDA approval review.  With the project's completion targeted for late summer 2008, the goal of the compensation plan is to motivate the field sales force and ensure the alignment of tactical activities with the product's strategic goals and budgets.
 
HighPoint Solutions has partnered with Qforma, a provider in advanced analytics and predictive modeling for pharmaceutical companies, on the initiative.  Using a physician target universe built from Qforma's iQMap, HighPoint Solutions will develop the incentive compensation plans for the launch product across all levels of the organization to drive the product's success.
 
"Our client is launching its new product in a crowded marketplace where the gold standard drug is going generic in 2010.  It is crucial that a plan is developed offering the right balance of motivation for the sales team and realistic product uptake, while remaining within the product's budget," explained Chris Colapietro, Vice President of Strategy and Marketing at HighPoint Solutions.